>So basically do you think that all plasma-derived therapeutics like OMRI has will be replaced in the future by synthetic, genetic-engineered therapeutics?<
Yes, eventually, provided that production cost for the recombinants is low enough.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.